PofoliaShared via Pofolia

npj Imaging· 2026Q1

Deep learning integration of ultrasound perfusion and stiffness maps predicts tumor response to treatment

Kyprianos Dimou, Yiannis Roussakis, Constantinos Zamboglou, Triantafyllos Stylianopoulos et al.

Short summary

A deep learning model combining ultrasound shear wave elastography (SWE) and contrast-enhanced ultrasound (CEUS) images achieved 91.2% accuracy in predicting tumor response to chemo-immunotherapy, outperforming models trained on either modality alone.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A combined deep learning model (CNN-combi) integrating ultrasound shear wave elastography (SWE) and contrast-enhanced ultrasound (CEUS) images predicted tumor response to chemo-immunotherapy with 91.2% overall accuracy.
  • Individual models trained on SWE (stiffness) and CEUS (perfusion) images achieved accuracies of 85.5% and 87.6%, respectively.
  • The combined model showed particularly high accuracy for responsive (95.8%) and non-responsive (96.0%) tumors.
  • The study used 587 SWE and CEUS images from murine models of breast cancer, sarcoma, and melanoma, classified by RECIST criteria.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract The complex tumor microenvironment and tumor heterogeneity make treatment responses highly variable, driving the shift toward biomarker-based therapy prediction. Ultrasound shear wave elastography (SWE) provides a simple and non-invasive method to measure tissue mechanical properties, such as tumor stiffness, by tracking shear wave propagation speed. Increased tumor stiffness is closely associated with compression of intratumoral blood vessels, which can severely limit blood flow within solid tumors, causing hypo-perfusion and hypoxia. These two abnormalities, in turn, hinder effective drug delivery and induce immunosuppression, which compromise the efficacy of cancer therapies. Tumor perfusion can be evaluated using contrast-enhanced ultrasound (CEUS), a minimally invasive imaging technique that employs microbubble contrast agents alongside ultrasound imaging to visualize blood flow and quantify tissue perfusion. In this study, we first developed CNN-ultra, a convolutional neural network trained separately on SWE and CEUS images to predict tumor response to chemo-immunotherapy in murine models of breast cancer, sarcoma, and melanoma. The dataset consisted of 587 SWE and CEUS images acquired prior to treatment, and tumor response was classified as responsive, stable, or non-responsive according to RECIST criteria (175 responsive, 136 stable, and 276 non-responsive cases). The overall accuracy of CNN-ultra was 0.855 for the SWE images and 0.876 for the CEUS images. Subsequently, we developed CNN-combi, an integrated model designed to combine features from both SWE and CEUS images to enhance predictive performance. Our CNN-combi model achieved an overall test accuracy of 0.912, with class-specific accuracies of 0.958 for responsive, 0.753 for stable, and 0.960 for non-responsive tumors, demonstrating the potential of the combination of SWE and CEUS as imaging biomarkers for predicting therapeutic response.

The authors' abstract, as published at the source. npj Imaging, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Radiology, Nuclear Medicine and Imaging

Radiology, Nuclear Medicine and ImagingMedicine